Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Reference34 articles.
1. Carr BI. Review of therapies for intermediate and advanced stage hepatocellular carcinoma, not suitable for curative therapies: a rapidly changing landscape HHS Public Access. Hepatoma Res. 2019;5:10.20517/2394–5079 2018.113.
2. Spreafico C, Sposito C, Vaiani M, Cascella T, Bhoori S, Morosi C, et al. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion. J Hepatol. 2018;68:724–32. https://doi.org/10.1016/j.jhep.2017.12.026.
3. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GAM, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–35. https://doi.org/10.1097/01.sla.0000197706.21803.a1.
4. Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: risk factors, screening and clinical presentation. World J Hepatol. 2019;11:261–72. https://doi.org/10.4254/wjh.v11.i3.261.
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–700. https://doi.org/10.1056/NEJM199603143341104.